FindMyRecallSubscribe
Class I: serious health riskTerminated

Sun Pharmaceutical Industries Vecuronium Bromide for Injection 10 mg* Recall

Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilize…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class I
Reported by FDA
Jan 16, 2019
Recall ID
D-0372-2019
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Vecuronium Bromide for Injection 10 mg* starting Jan 3, 2019. The FDA classified it as Class I (serious health risk) and published enforcement report D-0372-2019 on Jan 16, 2019. Reason: Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.

Product description

Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-931-40 [vial] NDC 47335-931-44 [carton]

Lot numbers, UPCs & expiration codes

Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0372-2019
Classification
Class I
Status
Terminated
Recall initiated
Jan 3, 2019
FDA report date
Jan 16, 2019
Quantity
12,534 cartons, 125,340 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0372-2019, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
81891
Address
270 Prospect Plains Rd
Code information
Lot #: JKS0443A, JKS0444A, JKS0477A, EXP 03/2019
Postal code
08512-3605
Report date
Jan 16, 2019
Product type
Drugs
Recall number
D-0372-2019
Classification
Class I
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
12,534 cartons, 125,340 vials
Termination date
Nov 3, 2021
Reason for recall
Presence of Particulate Matter: Foreign matter identified as glass detected in Vecuronium Bromide for Injection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vecuronium Bromide for Injection 10 mg*, *1mg/mL when reconstituted to 10 mL Lyophilized, 10 x 10 mg vials, Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway Halol-389 350, Gujarat, India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 NDC 47335-931-40 [vial] NDC 47335-931-44 [carton]
Distribution pattern
Nationwide in the USA
Recall initiation date
Jan 3, 2019
Initial firm notification
Letter
Center classification date
Jan 14, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0372-2019, published Jan 16, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls